EMERALD ADVISERS, LLC - OCULAR THERAPEUTIX INC ownership

OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 116 filers reported holding OCULAR THERAPEUTIX INC in Q4 2022. The put-call ratio across all filers is 0.82 and the average weighting 0.9%.

Quarter-by-quarter ownership
EMERALD ADVISERS, LLC ownership history of OCULAR THERAPEUTIX INC
ValueSharesWeighting
Q2 2024$142,053
-24.8%
20,7680.0%0.01%
-25.0%
Q1 2024$188,989
+104.0%
20,7680.0%0.01%
+100.0%
Q4 2023$92,625
+42.0%
20,7680.0%0.00%
+33.3%
Q3 2023$65,212
-72.4%
20,768
-54.6%
0.00%
-70.0%
Q2 2023$235,900
-2.1%
45,7170.0%0.01%
-16.7%
Q1 2023$240,929
-91.1%
45,717
-95.3%
0.01%
-90.8%
Q4 2022$2,712,327
-56.6%
965,241
-35.9%
0.13%
-59.4%
Q3 2022$6,252,000
+6.1%
1,506,456
+2.8%
0.32%
+6.6%
Q2 2022$5,892,000
-7.9%
1,465,702
+13.5%
0.30%
+24.2%
Q1 2022$6,395,000
-13.3%
1,291,905
+22.1%
0.24%
-10.3%
Q4 2021$7,372,000
-13.2%
1,057,727
+24.5%
0.27%
-11.7%
Q3 2021$8,496,000
-51.0%
849,600
-30.6%
0.31%
-51.3%
Q2 2021$17,349,000
-18.3%
1,223,500
-5.5%
0.63%
-17.6%
Q1 2021$21,248,000
-13.8%
1,294,850
+8.7%
0.77%
-6.2%
Q4 2020$24,648,0001,190,7030.82%
Other shareholders
OCULAR THERAPEUTIX INC shareholders Q4 2022
NameSharesValueWeighting ↓
SUMMER ROAD LLC 5,618,861$79,675,000100.00%
Opaleye Management Inc. 6,480,000$91,886,00015.26%
DELTEC ASSET MANAGEMENT LLC 2,167,313$30,732,0004.23%
Kamunting Street Capital Management, L.P. 624,201$8,851,0003.58%
GREAT POINT PARTNERS LLC 919,887$13,044,0002.74%
Endurant Capital Management LP 570,970$8,096,0002.22%
Rubric Capital Management LP 2,156,542$30,580,0001.92%
Affinity Asset Advisors, LLC 250,000$3,545,0001.27%
Altium Capital Management LP 256,152$3,632,0000.84%
Ikarian Capital, LLC 700,000$9,928,0000.80%
View complete list of OCULAR THERAPEUTIX INC shareholders